E. coli-derived recombinant human protein (amino acids D145-Q442) was used as the immunogen for the NADK2 antibody.
This gene encodes NAD kinase 2, a mitochondrial kinase that catalyzes the phosphorylation of NAD to yield NADP. Mutations in this gene result in 2,4-dienoyl-CoA reductase deficiency. Alternative splicing results in multiple transcript variants.
